COVID-19: VWF/ADAMTS13 Balance

COVID-19: VWF/ADAMTS13 Balance
Feb 10, 2022 9:30am

Thanks to Brandon Michael Henry MD, Cincinnati Children's Hospital Medical Center for drawing attention to his award-winning review, co-authored with Drs. Emmanuel Favaloro and Giuseppe Lippi, which details the relationship between von Willebrand factor and ADAMTS13 and applies the VWF/ADAMTS13 activity ratio to the thrombotic progression of the SARS-CoV2 infection. The authors review 67 primary research articles that appear to pinpoint the mechanisms for this progression, which resemble the mechanisms associated with thrombotic microangiopathies. Click here to read Favaloro EJ, Henry BM, Lippi G. Von Willebrand factor and ADAMTS13 in COVID-19 and beyond: a question of balance. Eur Med J Haematol 2021;9:55–68.

0 Comments

Thanks to Brandon Michael Henry MD, Cincinnati Children's Hospital Medical Center for drawing attention to his award-winning review, co-authored with Drs. Emmanuel Favaloro and Giuseppe Lippi, which details the relationship between von Willebrand factor and ADAMTS13 and applies the VWF/ADAMTS13 activity ratio to the thrombotic progression of the SARS-CoV2 infection. The authors review 67 primary research articles that appear to pinpoint the mechanisms for this progression, which resemble the mechanisms associated with thrombotic microangiopathies. Click here to read Favaloro EJ, Henry BM, Lippi G. Von Willebrand factor and ADAMTS13 in COVID-19 and beyond: a question of balance. Eur Med J Haematol 2021;9:55–68.

Leave A Comment

You must be logged in to Comment - Sign In